UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000014454
Receipt number R000016619
Scientific Title Evaluation of "SPIDER FX" and "PROTEGE RX" for Carotid Artery Stenting (ESPER-CAS)
Date of disclosure of the study information 2014/07/02
Last modified on 2021/01/07 14:19:08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of "SPIDER FX" and "PROTEGE RX" for Carotid Artery Stenting (ESPER-CAS)

Acronym

ESPER-CAS

Scientific Title

Evaluation of "SPIDER FX" and "PROTEGE RX" for Carotid Artery Stenting (ESPER-CAS)

Scientific Title:Acronym

ESPER-CAS

Region

Japan


Condition

Condition

carotid artery stenosis

Classification by specialty

Neurosurgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess the safety and efficacy of the "PROTEGE RX Carotid Stent System" and the "SPIDER FX Embolic Protection Device" used in carotid artery stenting in routine clinical practice under coverage of general health insurance.
To determine the occurrence of adverse events and device malfunctions and identify factors involved in their occurrence, in order to further promote the proper use of the products.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Others

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

All stroke, myocardial infarction, and death within 30 days of the stenting procedure

Key secondary outcomes

Adverse events
Ipsilateral ischemic stroke
Technical success and patency
Number of new ipsilateral ischemic lesions on MRI after the procedure (First imaging obtained 6 hours to 7 days after the stenting procedure)


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

To be included in this study, patients must be planned to undergo carotid artery stenting under coverage of general health insurance.

Key exclusion criteria

Patients will be excluded if they have any contraindication as per the package insert for the PROTETE RX Carotid Stent System or the SPIDER FX Embolic Protection Device. The products must be used only under coverage of health insurance.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Ichiro Nakahara

Organization

Kokura Memorial Hospital

Division name

Department of Neurosurgery

Zip code


Address

3-2-1 Asano, Kokurakita-ku, Kita-kyushu

TEL

093-511-2000

Email

ichiro@mub.biglobe.ne.jp


Public contact

Name of contact person

1st name
Middle name
Last name Tsuyoshi Ohta

Organization

Kokura Memorial Hospital

Division name

Department of Neurosurgery

Zip code


Address

3-2-1 Asano, Kokurakita-ku, Kita-kyushu

TEL

093-511-2000

Homepage URL


Email

espercas100@gmail.com


Sponsor or person

Institute

Kokura Memorial Hospital

Institute

Department

Personal name



Funding Source

Organization

Covidien Japan Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

順天堂大学医学部附属順天堂医院(東京都)
国立病院機構豊橋医療センター(愛知県)
国立循環器病研究センター病院(大阪府)
医真会八尾総合病院(大阪府)
国立病院機構九州医療センター(福岡県)
和歌山ろうさい病院(和歌山県)
藤田保健衛生大学(愛知県)
福岡大学病院(福岡県)
久留米大学(福岡県)
済生会和歌山病院(和歌山県)


Other administrative information

Date of disclosure of the study information

2014 Year 07 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2014 Year 04 Month 01 Day

Date of IRB

2014 Year 04 Month 01 Day

Anticipated trial start date

2014 Year 07 Month 01 Day

Last follow-up date

2015 Year 12 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Confirm that each patient meets all the inclusion criteria and does not meet any of the exclusion criteria. Obtain the patient's written informed consent to participate in the study before starting the study procedure. During the study period, patients will be enrolled consecutively until the predetermined sample size is achieved. Enrolling patients already treated with the study procedure is prohibited without exception. If the eligibility criteria checklist is not completed, enrollment will not be accepted until all the criteria are met.

This is an observational study of the use of the study devices in routine CAS procedure covered by the National Health Insurance, without any additional observation or examination other than in clinical practice. All the observations and examinations will be performed according to the Standard Operating Procedures of each study site.


Management information

Registered date

2014 Year 07 Month 02 Day

Last modified on

2021 Year 01 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016619


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name